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Ornithine decarboxylase which forms putrescine by 
the decarboxyalation of ornithine, is the first and prob-
ably the rate-limiting enzyme in the biosynthesis of the 
other polyamines, spermidine and spermine. Epidermal 
ornithine decarboxylase activity is greatly elevated in 
response to tumor promoting agents and ultraviolet 
light. The purpose of this paper is to report modification 
of ultraviolet-induced epidermal ornithine decarboxy-
lase activity by antiinflammatory agents. 
Topical triamcinolone acetonide and indomethacin 
were found to significantly inhibit the UV-B induction of 
epidermal ornithine decarboxylase in hairless mice 
when applied following ultraviolet light irradiation. The 
corticosteroid also showed inhibition of ultraviolet light 
increased epidermal DNA synthesis. Indomethacin failed 
to show any. inhibition of DNA synthesis. 
It is suggested that these assays may be used to study 
drugs that may modulate some ultraviolet light effects 
on the epidermis. 
The activities of ornithine decarboxylase (ODC) and the 
levels of its biosynthetic product, putrescine, are elevated in 
various hyperproliferative cell systems. Furthermore, recent 
studies have shown that in adult mouse epidermis very high 
levels of ODC activity may be obtained by application of certain 
phorbol esters [1,2]. It has also been shown that irradiation of 
adult hairless mouse skin with ultraviolet light (mainly 290-320 
nm, UV-B) will produce similarly high levels of ODC induc-
tion[3,4]. Epidermal macromolecular synthesis increases 48 hr 
following UV-B (5]. The induction of ODC occurred much 
earlier after UV-B than the subsequent increase in DNA syn-
thesis and, in fact, occurred while DNA synthesis was still 
suppressed (3]. 
A smaller increase of epidermal ODC activity has also been 
shown to be present in the epidermis of patients suffering from 
psoriasis, and the same group of investigators showed that the 
topical application of a glucocorticoid inhibited this elevated 
polyamine biosynthetic enzyme activity (6]. 
The purpose of these investigations, therefore, was to assess 
the effects of ·different antiinflammatory agents on UV -B-in-
duced epidermal ODC activity and DNA synthesis. 
MATERIALS AND METHODS 
2-3 month-old female hairless mice (Used strain) born within 7 days 
were randomized and housed 5 mice per cage for 1 week prior to 
experimentation. 
The UV-B source consisted of 6 FS40 Westinghouse sunlamp tubes 
(peak emission at 313 nm). The UV -B output in W /cm2 of this unit was 
measured using an IL-700 radiometer and an IL SEE 240 sensor fitted 
with a UV-B filter sensitive to radiation between 240 and 325 nm. It 
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was connected to an IL-720 photodosirneter with a feedback circuit to 
turn off the lamps at the predetermined dose. 
For irradiation mice were placed in a specially constructed 23 X 25 
em wire mesh and metal cage containing 24, 4 X 6 em compartments, 
and the sunlamps were routinely used at a distance of 13 em. The 
output of the sunlamps was measured at this distance. Care was taken 
to only use the center of the sunlamp to ensure uniform (± 5% range 
variation maximum) UV-B energy exposure. 
Triamcinolone acetonide and indomethacin was each dissolved in a 
vehicle containing 30% propylene glycol, 70% isopropyl alcohol and 
used in the concentration shown in Tables I and II. 20 ,ul of these drugs 
or vehicle alone were applied to the back skin immediately following 
UV-B irradiation. 
Assay of Ornithine Decarboxylase Activity 
24 hr after treatment, mice were killed by cervical dislocation and 
the epidermis from individual mice was separated by brief heat treat-
ment (55° for 30 sec). Epidermal ODC activity was determined by 
measuring the release of "C02 from DL-(l-' 4C) ornithine hydrochloride 
(specific activity, 49.9 mCi/mmole), obtained from New England Nu-
clear, Boston, Mass., as previously detailed [3]. The animals were 
sacrificed after 24 hr because th is is near to the peak induction time of 
epidermal ODC activity following this amount of UV -B [3]. 
Tritiated Thymidine Incorporation into Epidermal DNA 
The animals were injected intraperitoneally with 25 ,uCi of tritiated 
thymidine (Amersham/ Searle: specific activity 15.7 ,uCi/mM). The an-
imals were killed 1 hr later by cervical dislocation and skin specimens 
obtained for DNA extraction. The mice were sacrificed 48 hr after UV-
B because this was the time of maximum increase in epidermal DNA 
synthesis after this amount of UV-B [3]. 
The hydroxyapatite column extraction of epidermal DNA followed 
the procedure described by du Vivier et al [7]. The epidermis was 
removed as for the ODC assay. It was homogenized by a Brinkman 
PT10 homogenizer. The results of epidermal DNA synthesis were 
expressed as counts per minute per ,ug DNA. 
Statistical Analyses 
Experimental group means were compared for significance by Stu-
dent's t-test. 
RESULTS 
As summarized in Table I, topical administration ofO.Ol-0.1% 
triamcinolone acetonide resulted in a dose dependent (p < 
0.005) inhibition of UV-B induced ODC activity. Indomethacin 
(2.5%) was also effective, although to a lesser extent. 
The effects ofthese antiinflammatory drugs on UV -B induced 
DNA synthesis is shown in Table II. Triamcinolone acetonide 
(0.1 %) significantly (p < 0.005) inhibited UV -B induced epider-
mal DNA synthesis. 2.5% indomethacin did not significantly 
alter the increase in DNA synthesis following UV -B treatment. 
This concentration of indomethacin (2.5%) was chosen for 
the preliminary studies because it has been shown to be an 
optimum concentration in this vehicle for suppression of UV-
B-induced skin erythema [15]. It is planned to conduct further 
experiments to establish a dose-response relationship for indo-
methacin. 
DISCUSSION 
Exposure to UV -B radiation results in epidermal cell death, 
an increased mitotic index, and an acceleration of macromolec-
ular synthesis [3]. It has been recently shown that exposure of 
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TABLE I. Effects of triamcinolone acetonide (TMC) and 
indomethacin on UV-B induced epidermal ODC 
Experimental #per 
group" group 
UV-B+ 4 
vehicle 
UV-B + 9 
0.1% TMC 
UV-B+ 4 
0.05% TMC 
UV-B+ 4 
0.01% TMC 
UV-B+ 8 
vehicle 
UV-B + 2.5% 8 
indomethacin 
Non UV-B 12 
irradiated 
control 
Mean 
epidermal ODC 
(nmols C02/ 30 
min/ mg 
protein ± SO 
1.69 ± .36 
0.43 ± 19 
0.70 ± .20 
0.97 ± .11 
1.26 ± .44 
0.59 ± .21 
0.046 ± 0.029 
% 
inhib 
0 
75 
58 
43 
0 
53 
p-value rei 
to UV-B and 
vehicle' 
p < 0.005 
p < 0.005 
p < 0.005 
p < 0.005 
" The mice were treated with the drugs or vehicle immediately 
follow ing UV-B exposure (0.08 J / cm2). The mice were sacrificed 24 hr 
Later. 
'' p-values obtained using Student's t-test. 
TABLE II. Effects of triamcinolone acetonide, indomethacin on UV-
B-induced DNA synthesis 
Experimental #per Mean epidermal % 
p-value rei 
DNA synthesis to UV-B + group" group (cpm/ DNA) ± SD inhib vehicle" 
UV-B + 5 203 ± 47 0 
vehicle 
UV-B + 5 50± 19 75 p < 0.005 
triamcinolone 
acetonide 0.1 % 
Non-irradiated 5 87 ± 29 p < 0.005 
control 
UV-B +vehicle 4 417 ± 94 0 
UV-B + 4 346 ± 97 17 p < 0.2 
indomethacin 
2.5% 
Non-irradiated 4 154 ± 54 p < 0.01 
control 
" Mice were treated with the drugs or vehicle immediate ly following 
UV-B exposure (0.08 J / cm2 ). The mice were sacrificed 48 h later. 
" p -values were obtained using Student's t-test. 
hairless mice to UV -B irradiation leads to a marked increase in 
epidermal ODC activity [3,4]. Significant induction of epider-
mal ODC occuned within 2 to 4 hr after UV-B irradiation and 
reached a peak at 24 to 28 hr before declining to normal. This 
increased ODC activity occurred, therefore, at a time when 
epidermal DNA synthesis remained depressed following UV-B 
and before the epidermal proliferative activity occurred. It has 
also been previously shown that UV -B induced ODC activity is 
depressed by treatment with cychloheximide, an inhibitor of 
protein synthesis, and by 5-azacytidine, an inhibitor of nucleic 
acid synthesis [ 4]. Du Vivier et al described an assay for 
antiproliferative drugs using principally 254 nm UV -C radiation 
[7]. They found that certain antiinflammatory corticosteroids, 
as well as antiproliferative drugs, were active in their model and 
were able to inhibit post-UV epidermal DNA synthesis. Our 
results seem to parallel th ese findings using, however, a different 
source (UV-B) for increasing DNA synthesis. 
The mechanisms of inhibition of UV -B induced epidermal 
ODC by a topical steroid must remain speculative. ODC is 
thought to be specifically induced during the late G 1 phase of 
the cell cycle [8]. Interestingly, it has also been shown that 
corticosteroids are able to block epidermal cells during both the 
G 1 and G2 phases of the cell cycle [9). The ability of the 
corticosteroids to inhibit UV-B induced ODC activity and DNA 
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synthesis, therefore, again points to the ability of these drugs to 
act at several different points in the cell cycle. 
Corticosteroids have also been shown to reduce the elevated 
epidermal polyamine biosynthesis in psoriasis [6] and have 
been shown to profoundly depress ODC enzyme activity in 
thymus and other lymphatic tissues [10). 
There has been a report, however, that antiinflammatory 
corticosteroids did not inhibit phorbol ester-induced ODC ac-
tivity in the skin of mice [ll]. These results, which appear to be 
in conflict with the ability of corticosteroid to inhibit UV -B 
induced ODC activity, suggest that ultraviolet light and phorbol 
esters induce epidermal ODC by different mechanisms. The 
time course of response of induction of epidermal ODC is 
different after TPA phorbol ester induction [1] than after UV-
B induction [3]. It is intended to conduct further time-dose 
experiments with different corticosteroids to examine the pos-
sibility of time-frame shifts of ODC response, as well as mag-
nitude of ODC induction. Conversely, corticosteroids greatly 
stimulate ODC and S-adenosyl methionine decarboxylase ac-
tivity in parenchymal organs, such as the liver [12]. 
It therefore seems likely that there are different .mechanisms 
of action of these drugs on ODC activity in different tissues and 
in response to different stimuli. 
It is interesting that indomethacin was capable of inhibiting 
UV-B induced epidermal ODC 24 hr after UV-B. It has been 
shown previously that the same concentration of indomethacin 
was able to suppress UV-B-induced skin erythema for the 24 hr 
following UV -B; however, it had no modulating effect on DNA 
synthesis changes seen during 48 hours following UV-B [13). 
Indomethacin in our studies failed to s how any significant 
change in DNA synthesis following UV-B. 
Greaves and Sondergaard first reported prostaglandin-like 
activity in perfusates from human skin that had been irradiated 
with ultraviolet light [14] . One pharmacological effect of indo-
methacin is prostaglandin synthetase inhibition and studies 
have shown that topical indomethacin at this concentration 
(2.5%) reduces sunburn erythema and prostaglandin E levels in 
sunburned guinea pig skin [15]. It has also been shown that it 
is possible to inhibit TPA-induced epidermal ODC activity by 
treatment with topical indomethacin [16]. There may be, how-
ever, several other possible mechanisms for the apparent epi-
dermal ODC modulation by indomethacin other than postag-
landin synthetase inhibition. 
In summary, we have investigated the topical effects of 
certain antiinflammatory drugs on UV-B induction of the pol-
yamine biosynthetic enzyme ODC. A corticosteroid and indo-
methacin were able to inhibit UV-B induced ODC activity. It 
remains to be seen whether these assays can be usefully em-
ployed as a means of evaluating antiproliferative, antiinflam-
matory and, perhaps, photoprotectant properties of different 
drugs. 
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Bill Reed International Traveling Fellowships 
Three fellowships will be awarded this year as follows: 
1. The winner of the Postel" Session at the annual meeting of the European Society for Dermatological 
Research will be awarded $800 to help support a trip to attend the annual meeting of the American 
Academy of Dermatology. 
2. The winner of the Stelwagon Prize for the best paper presented at the Resident's Forum at the 
annual American Academy of Dermatology meeting will receive an $800 award to support a trip to Europe 
where the awardee will present a paper at the annual meeting of the British Association of Dermatologists 
in England. Further travel to European centers can also be arranged. 
3. A third award of $800 will be given to an Academically oriented dermatologist in the Private 
Practice of Clinical Dermatology, who has been out of training no more than 5 years. It is meant to 
support travel for educational purposes and to broaden contacts with dermatologic investigators. Anyone 
interested in applying for this award should send their curriculum vitae and a covering letter indicating 
how they plan to spend the award funds, to the Chairman of the Committee on International Affairs of 
the A.A.D. at the Academy office, 820 Davis Street, Evanston, Illinois 60201. The deadline for submission 
is September 1, 1980. Supporting letters from abroad relevant to the planned travel are desirable. The 
award will be announced in December and will be based on the originality and productivity of the 
applicant as well as the meritoriousness of the travel plans for continued clinical investigation. 
